ATS logo

ATSNYSE: ATS

Profile

Country:

Canada

IPO:

29 December 2009

Next earnings report:

08 November 2024

Last dividends:

N/A

Next dividends:

N/A
$2.97 B
-38%vs. 3y high
65%vs. sector
-53%vs. 3y high
48%vs. sector
-57%vs. 3y high
56%vs. sector
-49%vs. 3y high
49%vs. sector

Price

after hours | Fri, 01 Nov 2024 21:20:00 GMT
$30.51+$0.54(+1.79%)

Dividend

No data over the past 3 years
$507.26 M$25.78 M

Analysts recommendations

Institutional Ownership

ATS Latest News

New Strong Sell Stocks for October 4th
zacks.com04 October 2024 Sentiment: NEGATIVE

ATS, AZUL and BBC have been added to the Zacks Rank #5 (Strong Sell) List on October 4, 2024.

ATS Corporation: Diamond In The Rough
seekingalpha.com26 September 2024 Sentiment: POSITIVE

ATS provides vertically integrated automation solutions, focusing on Life Sciences and F&B sectors, with a robust backlog and strategic acquisitions enhancing growth potential. The macroeconomic environment, including lower interest rates and demographic changes, supports ATS's growth, especially in reshoring economies and increasing efficiency demands. Despite a healthy balance sheet, ATS faces risks from supply chain issues and cyclical industry exposure, with upcoming restructuring costs impacting short-term performance.

New Strong Sell Stocks for September 13th
zacks.com13 September 2024 Sentiment: NEGATIVE

ATS, BMTX and B have been added to the Zacks Rank #5 (Strong Sell) List on September 13, 2024.

ATS to Participate in the Jefferies Industrials Conference
businesswire.com19 August 2024 Sentiment: POSITIVE

CAMBRIDGE, Ontario--(BUSINESS WIRE)--ATS Corporation (TSX: ATS) (NYSE: ATS) (“ATS” or the “Company”) today announced that Andrew Hider, Chief Executive Officer and Ryan McLeod, Chief Financial Officer will participate in the Jefferies Industrials Conference in New York City, NY on September 5, 2024. ATS is scheduled to host a fireside chat at the event at 2:30 p.m. (ET). A webcast link of the live event will be available on the Investor Relations site at https://investors.atsautomation.com/ in.

ATS Corporation (ATS) Q1 2025 Earnings Call Transcript
seekingalpha.com10 August 2024 Sentiment: NEUTRAL

ATS Corporation (NYSE:ATS ) Q1 2025 Results Conference Call August 8, 2024 8:30 AM ET Company Participants David Galison - Head of Investor Relations Andrew Hider - Chief Executive Officer Ryan McLeod - Chief Financial Officer Conference Call Participants Michael Glen - Raymond James Patrick Sullivan - TD Cowen Joe Ritchie - Goldman Sachs Justin Keywood - Stifel Maxim Sytchev - National Bank Financial David Ocampo - Cormark Securities Patrick Baumann - JPMorgan Operator Hello, everyone, and welcome to the ATS Corporation First Quarter Conference Call and Webcast. This call is being recorded on August 8, 2024 at 8:30 a.m.

ATS (ATS) Lags Q1 Earnings Estimates
zacks.com08 August 2024 Sentiment: NEUTRAL

ATS (ATS) came out with quarterly earnings of $0.37 per share, missing the Zacks Consensus Estimate of $0.38 per share. This compares to earnings of $0.51 per share a year ago.

Earnings Preview: ATS (ATS) Q1 Earnings Expected to Decline
zacks.com01 August 2024 Sentiment: NEGATIVE

ATS (ATS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ATS Announces Dates of First Quarter Results Conference Call and Annual Meeting of Shareholders
businesswire.com22 July 2024 Sentiment: POSITIVE

CAMBRIDGE, Ontario--(BUSINESS WIRE)--ATS Corporation (TSX: ATS) (NYSE: ATS) (“ATS” or the “Company”) will report its financial results for the first quarter ended June 30, 2024, before markets open on Thursday August 8, 2024. At 8:30 a.m. eastern August 8, 2024, the Company will host a conference call and webcast of management's quarterly remarks and follow up question and answer period with analysts. The listen-only webcast can be accessed at https://events.q4inc.com/attendee/283321487, and th.

Kymera Therapeutics Presents New Preclinical Data for KT-621, a First-In-Class, Oral STAT6 Degrader at the ATS Annual Meeting
globenewswire.com22 May 2024 Sentiment: POSITIVE

KT-621, a potent, selective, oral STAT6 degrader, demonstrated comparable or superior activity to dupilumab in preclinical studies including an asthma model shared at the ATS Annual Meeting

InflaRx Presents New Analysis of PANAMO Phase III Trial in Severe COVID-19 at ATS 2024 Showing Potential Synergy With Vilobelimab When Used in Combination with Other Immunomodulators
globenewswire.com21 May 2024 Sentiment: POSITIVE

JENA, Germany, May 21, 2024 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, announced data presented at the American Thoracic Society (ATS) 2024 International Conference that is being held from May 17-22, 2024 in San Diego.

  • 1(current)

What type of business is ATS?

ATS Corporation, together with its subsidiaries, provides automation solutions worldwide. The company is also involved in planning, designing, building, commissioning, and servicing automated manufacturing and assembly systems, including automation products and test solutions. In addition, it offers pre-automation services comprising discovery and analysis, concept development, simulation, and total cost of ownership modelling; post automation services, including training, process optimization, preventative maintenance, emergency and on-call support, spare parts, retooling, retrofits, and equipment relocation; and contract manufacturing services, as well as after sales and services. Further, the company provides engineering design, prototyping, process verification, specification writing, software and manufacturing process controls development, standard automation products/platforms, equipment design and build, third-party equipment qualification, procurement and integration, automation system installation, product line commissioning, validation, and documentation services. Additionally, it offers value engineering, supply chain management, and integration and manufacturing capabilities, as well as other automation products and solutions; and software and digital solutions comprising connected factory floor management systems to capture, analyze, and use real time machine performance data to troubleshoot, deliver process and product solutions, prevent equipment downtime, drive operational efficiency, and unlock performance for sustainable production improvements. ATS Corporation serves life sciences, transportation and mobility, consumer products, food and beverage, electronics, nuclear, packaging, warehousing and distribution, and energy markets. The company was formerly known as ATS Automation Tooling Systems Inc. and changed its name to ATS Corporation in November 2022. ATS Corporation was founded in 1978 and is headquartered in Cambridge, Canada.

What sector is ATS in?

ATS is in the Industrials sector

What industry is ATS in?

ATS is in the Specialty Industrial Machinery industry

What country is ATS from?

ATS is headquartered in Canada

When did ATS go public?

ATS initial public offering (IPO) was on 29 December 2009

What is ATS website?

https://www.atsautomation.com

Is ATS in the S&P 500?

No, ATS is not included in the S&P 500 index

Is ATS in the NASDAQ 100?

No, ATS is not included in the NASDAQ 100 index

Is ATS in the Dow Jones?

No, ATS is not included in the Dow Jones index

When was ATS the previous earnings report?

No data

When does ATS earnings report?

The next expected earnings date for ATS is 08 November 2024